We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely
Nov 28
Australian (ASX) Healthcare Sector Analysis
UpdatedNov 30, 2022
DataAggregated Company Financials
Companies171
- 7D1.2%
- 3M1.2%
- 1Y-8.4%
- YTD-8.3%
The Healthcare industry is up 1.2% in the last week, with CSL up 0.8%. In the same time, Healius was down 12%. However, the industry is down 8.4% over the past year. Looking forward, earnings are forecast to grow by 16% annually.
Sector Valuation and Performance
Has the Australian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 30 Nov 2022 | AU$227.0b | AU$55.9b | AU$4.1b | 26.7x | 55.5x | 4.1x |
| Fri, 28 Oct 2022 | AU$211.0b | AU$56.2b | AU$4.2b | 27.7x | 50.7x | 3.8x |
| Sun, 25 Sep 2022 | AU$209.2b | AU$55.9b | AU$4.2b | 25.4x | 50x | 3.7x |
| Tue, 23 Aug 2022 | AU$225.9b | AU$54.4b | AU$4.8b | 29.1x | 47x | 4.2x |
| Thu, 21 Jul 2022 | AU$219.7b | AU$54.0b | AU$4.8b | 24.2x | 45.4x | 4.1x |
| Sat, 18 Jun 2022 | AU$196.1b | AU$53.8b | AU$4.8b | 24.1x | 40.7x | 3.6x |
| Mon, 16 May 2022 | AU$217.5b | AU$54.0b | AU$4.8b | 24.8x | 45x | 4x |
| Wed, 13 Apr 2022 | AU$209.1b | AU$56.7b | AU$4.6b | 26.5x | 45x | 3.7x |
| Fri, 11 Mar 2022 | AU$208.7b | AU$57.1b | AU$4.7b | 24.3x | 44.2x | 3.7x |
| Sun, 06 Feb 2022 | AU$211.3b | AU$55.6b | AU$4.7b | 29.1x | 45x | 3.8x |
| Tue, 04 Jan 2022 | AU$240.9b | AU$55.3b | AU$4.6b | 32x | 51.9x | 4.4x |
| Thu, 02 Dec 2021 | AU$237.2b | AU$56.2b | AU$4.7b | 30.5x | 50.4x | 4.2x |
| Sat, 30 Oct 2021 | AU$234.2b | AU$55.2b | AU$4.5b | 29.6x | 51.9x | 4.2x |
| Mon, 27 Sep 2021 | AU$241.4b | AU$55.8b | AU$4.6b | 30.8x | 52.4x | 4.3x |
| Wed, 25 Aug 2021 | AU$241.5b | AU$55.1b | AU$4.5b | 31.1x | 53.9x | 4.4x |
| Thu, 01 Jul 2021 | AU$226.8b | AU$55.1b | AU$4.5b | 30.7x | 50.2x | 4.1x |
| Sun, 04 Apr 2021 | AU$208.7b | AU$52.5b | AU$3.8b | 23.1x | 54.5x | 4x |
| Wed, 06 Jan 2021 | AU$211.4b | AU$50.7b | AU$3.1b | 31.9x | 68.2x | 4.2x |
| Sat, 10 Oct 2020 | AU$210.2b | AU$50.3b | AU$2.8b | 30.5x | 74.7x | 4.2x |
| Fri, 03 Jul 2020 | AU$204.0b | AU$49.6b | AU$2.5b | 27.4x | 81.8x | 4.1x |
| Mon, 06 Apr 2020 | AU$192.9b | AU$51.5b | AU$3.5b | 20.6x | 54.8x | 3.7x |
| Thu, 09 Jan 2020 | AU$197.2b | AU$49.6b | AU$3.7b | 21.4x | 53.1x | 4x |
Price to Earnings Ratio
54x
Current Industry PE
- Investors are relatively neutral on the Australian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 57.5x.
- The industry is trading close to its 3-year average PS ratio of 4.1x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 2.9% per year over the last three years.
- Revenues for these companies have grown 4.4% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Australian Healthcare sector?
| AU Market | 0.20% | |
| Healthcare | 1.16% | |
| Medical Equipment | 2.75% | |
| Biotech | 1.45% | |
| Healthtech | 0.39% | |
| Healthcare Services | -0.26% | |
| Life Sciences | -0.59% | |
| Pharma | -2.88% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio of 7.1x.
- Analysts are expecting annual earnings growth of 18.5%, which is higher than its past year's earnings decline of 25.3% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 54% over the next 5 years.
- However this is lower than its past earnings growth rate of 170% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 5.4% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CSL CSL | AU$300.11 | 0.8% +AU$1.2b | -2.9% | PE42.9x | |
| RHC Ramsay Health Care | AU$65.81 | 3.0% +AU$432.8m | -1.1% | PE56.7x | |
| COH Cochlear | AU$214.04 | 3.2% +AU$430.2m | 0.04% | PE48.7x | |
| NAN Nanosonics | AU$4.74 | 13.7% +AU$172.2m | -11.1% | PE382.9x | |
| ANN Ansell | AU$28.83 | 2.9% +AU$100.6m | -10.2% | PE15.3x |
